Postbiotics and Their Health Modulatory Biomolecules
- PMID: 36358990
- PMCID: PMC9688025
- DOI: 10.3390/biom12111640
Postbiotics and Their Health Modulatory Biomolecules
Abstract
Postbiotics are a new category of biotics that have the potential to confer health benefits but, unlike probiotics, do not require living cells to induce health effects and thus are not subject to the food safety requirements that apply to live microorganisms. Postbiotics are defined as a "preparation of inanimate microorganisms and/or their components that confers a health benefit on the host". Postbiotic components include short-chain fatty acids, exopolysaccharides, vitamins, teichoic acids, bacteriocins, enzymes and peptides in a non-purified inactivated cell preparation. While research into postbiotics is in its infancy, there is increasing evidence that postbiotics have the potential to modulate human health. Specifically, a number of postbiotics have been shown to improve gut health by strengthening the gut barrier, reducing inflammation and promoting antimicrobial activity against gut pathogens. Additionally, research is being conducted into the potential application of postbiotics to other areas of the body, including the skin, vagina and oral cavity. The purpose of this review is to set out the current research on postbiotics, demonstrate how postbiotics are currently used in commercial products and identify a number of knowledge gaps where further research is needed to identify the potential for future applications of postbiotics.
Keywords: SCFAs; antioxidant; bacteriocins; butyrate; epithelial barrier; exopolysaccharides; gut health; microbiome; postbiotics.
Conflict of interest statement
The authors declare no conflict of interest. The funders had no role in the writing of the manuscript.
Figures
References
-
- Hill C., Guarner F., Reid G., Gibson G.R., Merenstein D.J., Pot B., Morelli L., Canani R.B., Flint H.J., Salminen S., et al. Expert consensus document: The International Scientific Association for Probiotics and Prebiotics consensus statement on the scope and appropriate use of the term probiotic. Nat. Rev. Gastroenterol. Hepatol. 2014;11:506–514. doi: 10.1038/nrgastro.2014.66. - DOI - PubMed
-
- Camargo A.C., Todorov S.D., Chihib N.E., Drider D., Nero L.A. Lactic Acid Bacteria (LAB) and Their Bacteriocins as Alternative Biotechnological Tools to Control Listeria monocytogenes Biofilms in Food Processing Facilities. Mol. Biotechnol. 2018;60:712–726. doi: 10.1007/s12033-018-0108-1. - DOI - PubMed
-
- Maguire M., Maguire G. Gut dysbiosis, leaky gut, and intestinal epithelial proliferation in neurological disorders: Towards the development of a new therapeutic using amino acids, prebiotics, probiotics, and postbiotics. Rev. Neurosci. 2018;30:179–201. doi: 10.1515/revneuro-2018-0024. - DOI - PubMed
-
- Collado M.C., Salminen S., Vinderola G. Chapter 11-Postbiotics: Defining the impact of inactivated microbes and their metabolites on promotion of health. In: Koren O., Rautava S., editors. The Human Microbiome in Early Life. Academic Press; Cambridge, MA, USA: 2021. pp. 257–268.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
